D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KZR holding history
Kezar Life Sciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KZR overviewAll 13F holders of KZRFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −246,841−100.0% | Sold out | Holders |
| Q2 2024 | 246,841 | $148.1K | <0.1% | −172,584−41.1% | Reduced | Holders |
| Q1 2024 | 419,425 | $378.2K | <0.1% | +42,449+11.3% | Added | Holders |
| Q4 2023 | 376,976 | $357.1K | <0.1% | +333,301+763.1% | Added | Holders |
| Q3 2023 | 43,675 | $52.0K | <0.1% | +15,710+56.2% | Added | Holders |
| Q2 2023 | 27,965 | $68.5K | <0.1% | +27,965 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −95,021−100.0% | Sold out | Holders |
| Q1 2022 | 95,021 | $1.58M | <0.1% | +95,021 | New | Holders |